Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Stellisept mucosa in chronic leg ulcers
2006-000061-11Phase 3Completed
- Sponsor
- BODE Chemie
- Start
- Mar 2006
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of octenidine in stasis ulcer (2 arms), sponsored by BODE Chemie. Primary endpoints: antiseptic efficacy and local tolerability. Started Mar 2006; status: completed.
02
Drugs
octenidine
03
Conditions
stasis ulcer
Beyond the preview
Go deeper on 2006-000061-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000061-11.